This research investigated the repurposing of 51 existing drugs for COVID-19 treatment. Using molecular docking and simulation analysis, the study focused on five key protein targets involved in SARS-CoV-2 infection. The findings revealed several drug candidates with strong binding affinities and stable interactions, suggesting potential for further clinical investigation.
Publisher
Bioinformation
Published On
Feb 28, 2023
Authors
Piyush Bhanu, Anagha S Setlur, K Chandrashekar, Vidya Niranjan, Nisha Hemandhar Kumar, Sakshi Buchke, Jitendra Kumar, Anita Rani, Sushil M Tiwari, Vachaspati Mishra
Tags
COVID-19
drug repurposing
molecular docking
SARS-CoV-2
clinical investigation
binding affinities
drug candidates
Related Publications
Explore these studies to deepen your understanding of the subject.